Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Bupivacaine Dose for Initiation of Labor Epidural Pain Relief
NCT04814537Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Feb 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in labor pain, sponsored by Brigham and Women's Hospital. Started Feb 2021; status: completed.
02
Drugs
bupivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on NCT04814537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04814537.